About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 675 trials

CompletedA Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)This is a randomized, double-blind, placebo-controlled, multinational Phase 2 study to evaluate and compare oral AT-101 in combination with docetaxel and prednisone versus…NCT00571675·Colorado Springs, Colorado and 34 others CompletedStudy of TAS3681 in Metastatic Castration Resistant Prostate CancerThe purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3681 (Escalation Phase) and to…NCT02566772·Sacramento, California and 32 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialThis randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of…NCT07200830·Anchorage, Alaska and 137 others

CompletedThe Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisThis study is being conducted to evaluate the effect of an investigational drug on bone loss in men with prostate cancer who are receiving Androgen Deprivation Therapy (ADT).NCT00171639·Tucson, Arizona and 6 others

CompletedStudy of Aranesp to Treat Anemia in Prostate Cancer Patients.The purpose of this study is to see if darbepoetin alfa is an effective treatment for anemia in prostate cancer patients and, if so, what dose is most effective.NCT00245895·Portland, Oregon and 1 other

UnknownI-125 Versus Pd-103 for Low Risk Prostate CancerObjective: To test the hypothesis that the shorter half-life of Pd-103 versus I-125, will increase the rate of tumor eradication.NCT00494039·Seattle, Washington

TerminatedS0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian CancerRATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells.NCT00023634·Bay City, Michigan and 12 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

CompletedMitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)To determine the time to progression produced by the combination of Novantrone (mitoxantrone) and Erbitux (cetuximab) versus Novantrone alone in metastatic AIPC patients…NCT00661492·Phoenix, Arizona and 54 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 173 others

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

CompletedMifepristone (RU-486) in Androgen Independent Prostate CancerThe purpose of this study is to determine the effects (good and bad) that mifepristone has on patients with androgen independent prostate cancer.NCT00140478·Washington D.C., District of Columbia and 3 others

CompletedA Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.NCT00036543·Homewood, Alabama and 231 others

CompletedPROvenge Treatment and Early Cancer TreatmentThe PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer.NCT00779402·Berkeley, California and 17 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC).NCT06925737·Phoenix, Arizona and 302 others

UnknownExternal Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the ProstateThis prospective study at MAMC evaluates the utility of a rigid pelvic external immobilization compared to limited immobilization using a novel real-time localization system of…NCT01588938·Tacoma, Washington

CompletedA Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerThe rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients…NCT00116753·Homewood, Alabama and 55 others

TerminatedImmune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TThe purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).NCT01727154·Scottsdale, Arizona and 38 others

CompletedOpen- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate CancerThe ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-metastatic prostate cancer…NCT03686683·Gilbert, Arizona and 55 others

CompletedImmunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerThe purpose of this study is to test if interleukin-2, a drug that stimulates the immune system, can be used after chemotherapy to slow the progression of your disease.NCT00283829·Seattle, Washington

PreviousPage 14 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma